Profile data is unavailable for this security.
About the company
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line, providing Immediate Immunity for the prevention of scours in newborn dairy and beef calves. It expanded this line into four different products with formulations targeting E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. This product line provides Immediate Immunity to newborn calves. The Company is engaged in the development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. The Company’s products reduce the use of traditional antibiotics in food producing animals.
- Revenue in USD (TTM)17.47m
- Net income in USD-5.77m
- Incorporated1987
- Employees72.00
- LocationImmuCell Corp56 Evergreen DrivePORTLAND 04103United StatesUSA
- Phone+1 (207) 878-2770
- Fax+1 (302) 655-5049
- Websitehttps://immucell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Singular Genomics Systems Inc | 2.91m | -94.82m | 38.21m | 255.00 | -- | 0.2131 | -- | 13.12 | -1.30 | -1.30 | 0.04 | 2.42 | 0.0098 | 0.2182 | 3.94 | 11,415.69 | -31.96 | -- | -33.80 | -- | -19.17 | -- | -3,257.30 | -- | 9.77 | -- | 0.0474 | -- | 280.52 | -- | -4.34 | -- | -- | -- |
Marker Therapeutics Inc | 3.31m | -14.05m | 38.53m | 8.00 | -- | 2.75 | -- | 11.64 | -1.59 | -0.933 | 0.3753 | 1.58 | 0.1285 | -- | 1.93 | 413,892.50 | -54.49 | -53.74 | -69.03 | -62.25 | -- | -- | -424.20 | -1,438.71 | -- | -- | 0.00 | -- | -5.76 | 74.27 | 28.97 | -- | -- | -- |
SAB Biotherapeutics Inc | 4.09m | -27.21m | 38.93m | 56.00 | -- | 1.45 | -- | 9.51 | -5.55 | -5.55 | 0.8264 | 2.92 | 0.1013 | -- | 0.6328 | 73,122.32 | -67.32 | -- | -99.80 | -- | -- | -- | -664.53 | -- | -- | -66.42 | 0.2128 | -- | -60.73 | -- | -9.31 | -- | -- | -- |
Nymox Pharmaceutical Corp | 0.00 | -4.87m | 39.17m | 3.00 | -- | -- | -- | -- | -0.0536 | -0.0536 | 0.00 | -0.0204 | 0.00 | -- | -- | -- | -255.75 | -264.40 | -- | -464.48 | -- | -- | -- | -13,001.67 | -- | -42.44 | -- | -- | -- | -- | 47.55 | -- | -- | -- |
NKGen Biotech Inc | 0.00 | -52.37m | 39.40m | -- | -- | -- | -- | -- | -3.83 | -3.83 | 0.00 | -1.86 | 0.00 | -- | -- | -- | -52.61 | -- | -66.52 | -- | -- | -- | -- | -- | -- | -0.9041 | -- | -- | -- | -- | 559.13 | -- | -- | -- |
Fortress Biotech Inc | 80.97m | -84.33m | 39.88m | 187.00 | -- | 1.16 | -- | 0.4925 | -12.29 | -12.29 | 11.51 | 1.87 | 0.3416 | 2.16 | 4.43 | 433,000.00 | -77.03 | -52.23 | -140.10 | -102.37 | 64.97 | 62.90 | -225.53 | -281.57 | 0.8916 | -12.49 | 1.37 | -- | 10.11 | 34.44 | -33.80 | -- | -7.52 | -- |
CASI Pharmaceuticals Inc | 42.26m | -40.42m | 39.96m | 224.00 | -- | 1.39 | -- | 0.9456 | -3.00 | -3.00 | 3.15 | 2.16 | 0.4182 | 2.09 | 3.49 | 188,678.60 | -38.41 | -35.39 | -66.12 | -45.34 | 63.84 | -- | -91.84 | -211.35 | 4.17 | -26.55 | 0.00 | -- | 42.89 | -- | -11.90 | -- | 43.12 | -- |
DURECT Corp | 8.55m | -27.62m | 39.97m | 72.00 | -- | 2.70 | -- | 4.68 | -1.12 | -1.12 | 0.3258 | 0.4956 | 0.1624 | 0.7927 | 3.65 | -- | -52.47 | -37.34 | -124.79 | -53.44 | 79.91 | 91.83 | -323.16 | -139.11 | 1.20 | -55.63 | 0.5299 | -- | -55.67 | -10.96 | 21.82 | -- | -- | -- |
Cyclo Therapeutics Inc | 1.08m | -20.06m | 40.20m | 8.00 | -- | 8.40 | -- | 37.35 | -1.33 | -1.33 | 0.0679 | 0.1666 | 0.1233 | 0.387 | 12.14 | 134,551.30 | -229.72 | -132.22 | -727.50 | -215.17 | 90.85 | 90.37 | -1,863.35 | -1,114.04 | 1.42 | -2,769.34 | 0.00 | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
ImmuCell Corp | 17.47m | -5.77m | 41.00m | 72.00 | -- | -- | -- | 2.35 | -0.7454 | -0.7454 | 2.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.15 | 40.04 | -33.05 | -12.64 | -- | -23.55 | -- | -- | -5.90 | 9.72 | -131.57 | -- | -- | -- |
Vyne Therapeutics Inc | 424.00k | -27.87m | 41.73m | 10.00 | -- | 0.4703 | -- | 98.43 | -6.84 | -7.00 | 0.0413 | 6.29 | 0.0061 | -- | 0.1639 | 42,400.00 | -40.27 | -108.41 | -45.86 | -138.57 | -- | -- | -6,573.82 | -1,907.10 | -- | -- | 0.00 | -- | -11.11 | -47.51 | 17.89 | -- | -- | -- |
Rapid Micro Biosystems Inc | 22.52m | -52.47m | 42.07m | 193.00 | -- | 0.3558 | -- | 1.87 | -1.22 | -1.22 | 0.5234 | 2.78 | 0.1348 | 1.36 | 4.07 | 116,678.80 | -31.41 | -- | -35.44 | -- | -24.36 | -- | -232.99 | -- | 5.29 | -- | 0.0026 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
SensaSure Technologies Inc | 1.15k | -746.37k | 42.26m | 1.00 | -- | -- | -- | 36,749.47 | -0.0132 | -0.0132 | 0.00002 | -0.0212 | 0.0135 | -- | 0.7986 | 1,150.00 | -891.64 | -- | -- | -- | -- | -- | -66,024.35 | -- | -- | -92.16 | -- | -- | -31.15 | -- | 17.62 | -- | -- | -- |
Viracta Therapeutics Inc | 0.00 | -51.06m | 42.41m | 40.00 | -- | 3.28 | -- | -- | -1.32 | -1.32 | 0.00 | 0.4686 | 0.00 | -- | -- | 0.00 | -66.88 | -86.35 | -97.91 | -106.38 | -- | -- | -- | -11,853.94 | -- | -141.21 | 0.5798 | -- | -- | -- | -3.78 | -- | -- | -- |
Tiziana Life Sciences Ltd - ADR | 0.00 | -15.40m | 42.65m | 9.00 | -- | 2.18 | -- | -- | -0.1496 | -0.1496 | 0.00 | 0.1914 | 0.00 | -- | -- | 0.00 | -40.89 | -- | -50.40 | -- | -- | -- | -- | -- | -- | -2,083.71 | 0.0183 | -- | -- | -- | 34.25 | -- | -- | -- |
Benson Hill Inc | 473.34m | -111.25m | 43.26m | 270.00 | -- | 0.5028 | -- | 0.0914 | -0.5914 | -0.6131 | 2.52 | 0.4129 | 1.22 | 10.27 | 14.81 | 1,753,096.00 | -28.68 | -- | -38.28 | -- | 4.99 | 3.18 | -23.50 | -40.73 | 0.9166 | -2.33 | 0.4509 | -- | 24.16 | 156.43 | -11.58 | -- | 63.78 | -- |